Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$16.98 USD
+0.17 (1.01%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $16.98 0.00 (0.00%) 6:44 PM ET
3-Hold of 5 3
B Value D Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Teva Pharmaceutical Industries Ltd. [TEVA]
Reports for Purchase
Showing records 101 - 120 ( 460 total )
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Optimism on Near-Term Opioid Settlement Offsets Mediocre Q2
Provider: G.RESEARCH, LLC
Analyst: KEDRA K
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Provider: Zacks Investment Research
Analyst: Research Department
Company: Teva Pharmaceutical Industries Ltd.
Industry: Medical - Generic Drugs
Comprehensive Technical and Fundamental Analysis for TEVA.
Provider: Stock Traders Daily
Analyst: Research Department